Knowledge Hub

Insulin Pens - Medical Devices Pipeline Assessment, 2016

Press Release   •   Oct 28, 2016 05:03 EDT

MarketResearchReports.biz has recently announced the addition of a market study “ Insulin Pens - Medical Devices Pipeline Assessment, 2016”, is a comparative analysis of the global market.

Insulin Pens - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, Insulin Pens - Medical Devices Pipeline Assessment, 2016" provides an overview of Insulin Pens currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Pens pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Insulin Pens under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Insulin Pens and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/718329

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Insulin Pens under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the products current stage of development, territory and estimated launch date

Table Of Content

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 5

2 Introduction 6

2.1 Insulin Pens Overview 6

3 Products under Development 7

3.1 Insulin Pens - Pipeline Products by Stage of Development 7

3.2 Insulin Pens - Pipeline Products by Segment 8

3.3 Insulin Pens - Pipeline Products by Territory 9

3.4 Insulin Pens - Pipeline Products by Regulatory Path 10

3.5 Insulin Pens - Pipeline Products by Estimated Approval Date 11

4 Insulin Pens - Pipeline Products under Development by Companies 12

4.1 Insulin Pens Companies - Pipeline Products by Stage of Development 12

4.2 Insulin Pens - Pipeline Products by Stage of Development 13

5 Insulin Pens Companies and Product Overview 14

5.1 Becton, Dickinson and Company Company Overview 14

5.1.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Calibra Medical, Inc. Company Overview 16

5.2.1 Calibra Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Cambridge Consultants Limited Company Overview 17

5.3.1 Cambridge Consultants Limited Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 Companion Medical, Inc. Company Overview 19

5.4.1 Companion Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 Emperra GmbH E-Health Technologies Company Overview 20

5.5.1 Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 MedPro Safety Products, Inc. Company Overview 22

5.6.1 MedPro Safety Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 MicroPort Scientific Corporation Company Overview 23

5.7.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 Sanofi Company Overview 25

5.8.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 25

6 Insulin Pens- Recent Developments 27

6.1 Mar 23, 2016: B. Braun's growth trend continues 27

6.2 Mar 10, 2016: Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer 28

6.3 Mar 08, 2016: Antares Pharma Reports Fourth Quarter and Full Year 2015 Operating and Financial Results 28

6.4 Mar 07, 2016: InsuLine Medical to Raise Funds in Financing Round 30

6.5 Feb 09, 2016: Sanofi Delivered 2015 Business EPS Up 8.5% On A Reported Basis And Stable At Constant Exchange Rates Consistent With Guidance 30

6.6 Feb 04, 2016: Sanofi India Announces Results for the Quarter & Year Ended December 31, 2015 38

6.7 Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter 38

6.8 Jan 26, 2016: Antares Pharma Announces CEO Transition 39

6.9 Jan 21, 2016: U.S. Food and Drug Administration Approves Humulin R U-500 KwikPen 40

6.10 Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges 40